Artis TechBio II, L.P.

Artis TechBio II, L.P. is a Delaware limited partnership that first filed a Form D on March 31, 2022 and most recently amended it on December 14, 2023, describing itself as a venture capital fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(7) and covers pooled investment fund interests. Artis TechBio II, L.P. reported $140,812,500 sold from 77 investors of a $300,000,000 total offering as of the Form D filed December 14, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names INVICTA CAPITAL LLC (CRD 288101), associated with None; FNEX CAPITAL LLC (CRD 166316), associated with None as recipients of sales compensation soliciting in AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, NC, NE, NJ, NY, OH, PA, SC, TX, UT, VA, WA, WV. The issuer's address of record is 499 Jackson Street, Suite 400, San Francisco, CA 94111.